Medica SurB de CV (MEX:MEDICAB) LT-Debt-to-Total-Asset: 0.21 (As of Dec. 2025)

What is Medica SurB de CV LT-Debt-to-Total-Asset?

Medica SurB de CV MEX:MEDICAB 81 LT-Debt-to-Total-Asset is 0.21 as of Dec. 2025. GuruFocus rates MEX:MEDICAB with a GF Score™ of 81/100 and a GF Value™ of MXN46.72 (Modestly Overvalued). The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Medica SurB de CV's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.21.

Medica SurB de CV's long-term debt to total assets ratio increased from Dec. 2024 (0.00) to Dec. 2025 (0.21). It may suggest that Medica SurB de CV is progressively becoming more dependent on debt to grow their business.

Medica SurB de CV (MEX:MEDICAB) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Medica SurB de CV LT-Debt-to-Total-Asset Related Terms

Medica SurB de CV LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Medica SurB de CV's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medica SurB de CV LT-Debt-to-Total-Asset Chart

Medica SurB de CV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.15

0.22

0.24

0.00

0.21

Medica SurB de CV Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.00	0.00	0.00	0.21	0.21

81GF Score

Medica Sur SAB de CV MEX:MEDICAB

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medica SurB de CV LT-Debt-to-Total-Asset Calculation

Medica SurB de CV's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	1003.212	/	4776.726
	=	0.21

Medica SurB de CV's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	1003.212	/	4776.726
	=	0.21

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.21 mean?

Medica SurB de CV (MEX:MEDICAB) has a LT-Debt-to-Total-Asset of 0.21 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Medica SurB de CV and its competitors.

Is Medica SurB de CV's LT-Debt-to-Total-Asset too high?

Medica SurB de CV's current LT-Debt-to-Total-Asset is 0.21. Overall, Medica SurB de CV has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Medica SurB de CV's LT-Debt-to-Total-Asset compare to HCA and THC?

Medica SurB de CV's LT-Debt-to-Total-Asset of 0.21 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Healthcare Providers & Services company?

A good LT-Debt-to-Total-Asset depends on the Healthcare Providers & Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Medica SurB de CV and its competitors. Medica SurB de CV's current LT-Debt-to-Total-Asset is 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medica SurB de CV stock overvalued right now?

Based on GuruFocus' analysis, Medica SurB de CV (MEX:MEDICAB) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN46.72, compared to a current price of MXN59.40 — trading 27.1% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.21. Medica SurB de CV's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Medica SurB de CV (MEX:MEDICAB), the current LT-Debt-to-Total-Asset is 0.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medica SurB de CV (MEX:MEDICAB) Overvalued in 2026?

Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued. The current stock price of MXN59.40 is trading 27.1% above its estimated GF Value™ of MXN46.72. GuruFocus considers Medica SurB de CV to be Modestly Overvalued.

Key valuation signals for MEX:MEDICAB:

LT-Debt-to-Total-Asset: 0.21
GF Value™: MXN46.72 vs. price of MXN59.40 (27.1% above fair value)
GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the MEX:MEDICAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medica SurB de CV Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies HCA XTER:FRE SAU:4013 XKLS:5225 THC BSP:RDOR3 DVA NSE:APOLLOHOSP XTER:FME BOM:543220 SZSE:300015 EHC ENSG BKK:BDMS UHS BOM:532843 ISX:SRAJ ASX:RHC ADX:PUREHEALTH PACS

Address Puente de Piedra 150, Col. Toriello Guerra,Tlalpan, Mexico, DF, MEX, 14050

Website http://www.medicasur.com.mx

Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.

81GF Score

Get the complete analysis for MEX:MEDICAB

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN59.40

Price

MXN46.72

GF Value

View MEX:MEDICAB Analysis

See LT-Debt-to-Total-Asset data for all stocks →